Related Experiment Video

Updated: Aug 15, 2026

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
06:32

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

Hepatitis B vaccination in children: five year booster study

A Milne1, S Krugman, J A Waldon

  • 1Hepatitis Research Unit, Whakatane, New Zealand.

The New Zealand Medical Journal
|August 26, 1992
PubMed

Insights

Hepatitis B vaccination in children provides protection for at least five years. Booster doses are not needed within this timeframe if initial vaccine response is strong, aiding hepatitis B control in endemic regions.

Area of Science:

  • Immunology
  • Vaccinology
  • Pediatrics

Background:

  • Hepatitis B virus (HBV) infection is a significant global health concern, particularly in endemic areas.
  • Effective vaccination strategies are crucial for controlling HBV transmission in pediatric populations.

Purpose of the Study:

  • To assess the duration of protective immunity conferred by hepatitis B vaccines in children.
  • To determine the necessity of booster doses within five years post-primary immunization.

Main Methods:

  • A cohort of 318 children received a 2-microgram intramuscular dose of recombinant DNA vaccine (rDNAV).
  • These children had previously received plasma-derived vaccine (PDV) doses five years prior.
  • Hepatitis B virus (HBV) seromarkers were analyzed pre- and post-booster administration.

Main Results:

  • All children demonstrated an anamnestic response to the booster dose.
  • The geometric mean titre (GMT) of antibody to hepatitis B surface antigen (antiHBs) significantly increased from 89 to 4777 IU/L.
  • Antibody detection rates were high, with 94% positive before the booster and 96.5% positive shortly after.

Conclusions:

  • Satisfactory initial seroconversion indicates sustained protection for at least five years.
  • Booster doses for hepatitis B are not required for children within five years if primary immunization is successful.
  • These findings support simplified hepatitis B vaccination schedules for population control in endemic regions.
Abstract

More Related Videos

A Suction Blister Protocol to Study Human T-cell Recall Responses In Vivo11:17

A Suction Blister Protocol to Study Human T-cell Recall Responses In Vivo

Published on: August 11, 2018

Multicellular Human Alveolar Model Composed of Epithelial Cells and Primary Immune Cells for Hazard Assessment09:27

Multicellular Human Alveolar Model Composed of Epithelial Cells and Primary Immune Cells for Hazard Assessment

Published on: May 6, 2020

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Chickenpox01:20

Chickenpox

Chickenpox is an acute, highly contagious disease caused by the varicella-zoster virus (VZV), a double-stranded DNA virus belonging to the Herpesviridae family. Its transmission occurs primarily through the inhalation of respiratory droplets or direct contact with vesicular fluid from skin lesions. The incubation period typically ranges from 10 to 21 days, during which the virus replicates and disseminates through sequential phases within the host. Although generally self-limiting in children,...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...